ReNeuron Group (RENE) RNS Announcements

Add to Alert list
Date Time Source Announcement
05 Jun 2013 04:35 PM
RNS
Price Monitoring Extension
28 May 2013 07:00 AM
RNS
Stroke Trial Update
19 Apr 2013 07:00 AM
RNS
Presentation on Mechanisms of Action
17 Apr 2013 04:40 PM
RNS
Second Price Monitoring Extn
17 Apr 2013 04:35 PM
RNS
Price Monitoring Extension
04 Apr 2013 04:40 PM
RNS
Second Price Monitoring Extn
04 Apr 2013 04:35 PM
RNS
Price Monitoring Extension
28 Mar 2013 07:02 AM
RNS
Collaboration with Cell Therapy Catapult
27 Mar 2013 07:00 AM
RNS
Dosing Completed in Stroke Trial
26 Mar 2013 07:00 AM
RNS
Approvals for Stem Cell Trial in CLI
19 Mar 2013 04:40 PM
RNS
Second Price Monitoring Extn
19 Mar 2013 04:35 PM
RNS
Price Monitoring Extension
11 Mar 2013 07:00 AM
RNS
Wins Two Biomedical Catalyst Grants
06 Mar 2013 04:35 PM
RNS
Price Monitoring Extension
25 Feb 2013 07:00 AM
RNS
AIM Rule 17 Notification
29 Jan 2013 07:00 AM
RNS
Stroke Trial Update: Final Cohort Begins Dosing
11 Jan 2013 04:40 PM
RNS
Second Price Monitoring Extn
11 Jan 2013 04:35 PM
RNS
Price Monitoring Extension
04 Dec 2012 07:01 AM
RNS
ReNeuron to Present at UK Stroke Forum
04 Dec 2012 07:00 AM
RNS
Interim Results
22 Nov 2012 07:00 AM
RNS
Non-Clinical Data
21 Nov 2012 07:00 AM
RNS
Notification of Interim Results
17 Oct 2012 07:00 AM
RNS
Further Progress with Stroke Trial
21 Sep 2012 12:39 PM
RNS
TR-1: Notification of Major Interest in Shares
14 Sep 2012 10:00 AM
RNS
Directors' Interest in Shares and Share Options
11 Sep 2012 10:38 AM
RNS
Results of 2012 Annual General Meeting
11 Sep 2012 07:00 AM
RNS
AGM Trading Update
14 Aug 2012 07:00 AM
RNS
Stroke Trial Update
07 Aug 2012 09:42 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16 Jul 2012 07:00 AM
RNS
Posting of Annual Report & Notice of AGM
05 Jul 2012 04:40 PM
RNS
Second Price Monitoring Extn
05 Jul 2012 04:35 PM
RNS
Price Monitoring Extension
28 Jun 2012 07:01 AM
RNS
SSAG and Non-Executive Board Changes
28 Jun 2012 07:00 AM
RNS
Preliminary Results
19 Jun 2012 07:00 AM
RNS
Notification of Preliminary Results
15 Jun 2012 07:00 AM
RNS
Presents Further Data
14 Jun 2012 07:00 AM
RNS
PISCES Trial Interim Data
08 Jun 2012 10:13 AM
RNS
Notice of Major Interest in Shares
21 May 2012 07:00 AM
RNS
Presentation at World Stem Cells Congress
16 May 2012 07:00 AM
RNS
Cell Manufacturing Contract
11 May 2012 11:09 AM
RNS
Notifications of Major Interests in Shares
08 May 2012 10:52 AM
RNS
TR-1: Notification of Major Interest in Shares
03 May 2012 12:21 PM
RNS
Admission of Open Offer Shares
27 Apr 2012 03:37 PM
RNS
TR-1: Notification of Major Interest in Shares
27 Apr 2012 03:26 PM
RNS
TR-1: Notification of Major Interest in Shares
27 Apr 2012 07:00 AM
RNS
Result of Placing and Open Offer
20 Apr 2012 02:54 PM
RNS
Result of General Meeting
20 Apr 2012 07:00 AM
RNS
Investor Conference
19 Apr 2012 10:16 AM
RNS
Notification of Major Interest in Shares
03 Apr 2012 07:00 AM
RNS
Placing and Open Offer

ReNeuron Group plc is a United Kingdom-based clinical-stage stem cell company. The Company is engaged in the development of stem cell therapies targeting areas of unmet or poorly met medical need. It has developed a stem cell-derived, exosome-based, drug delivery platform with customizable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several exosome producer cell lines, its CustomEX platform can be optimized for specific tissue targets and payloads, leading to improvements in therapeutic outcome and a reduction in off-target effects. It offers a delivery mechanism for a variety of payloads such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. Through its conditionally immortalized induced pluripotent stem cell (iPSC) platform, it has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.

It listed on AIM in 2006 under the ticker RENE.

UK 100

Latest directors dealings